|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
189 a.a.
|
 |
|
|
|
|
|
|
|
190 a.a.
|
 |
|
|
|
|
|
|
|
330 a.a.
|
 |
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Lyase/lyase/signaling protein
|
 |
|
Title:
|
 |
Complex of gs-alpha with the catalytic domains of mammalian cyclase: complex with adenosine 5'-(alpha thio)-triphosphat mg, and mn
|
|
Structure:
|
 |
Adenylate cyclase, type v. Chain: a. Fragment: c1a domain of adenylyl cyclase. Synonym: protein vc1. Engineered: yes. Mutation: yes. Adenylate cyclase, type ii. Chain: b. Fragment: c2a domain of adenylyl cyclase.
|
|
Source:
|
 |
Canis lupus familiaris. Dog. Organism_taxid: 9615. Strain: familiaris. Tissue: cardiac muscle. Cellular_location: cytoplasm. Gene: adenylyl cyclase type v. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008.
|
|
Biol. unit:
|
 |
Hexamer (from
)
|
|
Resolution:
|
 |
|
3.00Å
|
R-factor:
|
0.220
|
R-free:
|
0.266
|
|
|
Authors:
|
 |
J.J.G.Tesmer,S.R.Sprang
|
Key ref:
|
 |
J.J.Tesmer
et al.
(1999).
Two-metal-Ion catalysis in adenylyl cyclase.
Science,
285,
756-760.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
16-Apr-99
|
Release date:
|
31-Aug-99
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
|
|
|
P30803
(ADCY5_CANFA) -
Adenylate cyclase type 5
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1265 a.a.
189 a.a.*
|
|
|
|
|
|
|
 |
 |
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
Chains A, B:
E.C.4.6.1.1
- Adenylate cyclase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
ATP = 3',5'-cyclic AMP + diphosphate
|
 |
 |
 |
 |
 |
ATP
Bound ligand (Het Group name = )
matches with 93.75% similarity
|
=
|
3',5'-cyclic AMP
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Cofactor:
|
 |
Pyridoxal 5'-phosphate
|
 |
 |
 |
 |
 |
Pyridoxal 5'-phosphate
|
|
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
membrane
|
5 terms
|
 |
|
Biological process
|
intracellular signal transduction
|
25 terms
|
 |
|
Biochemical function
|
nucleotide binding
|
10 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Science
285:756-760
(1999)
|
|
PubMed id:
|
|
|
|
|
| |
|
Two-metal-Ion catalysis in adenylyl cyclase.
|
|
J.J.Tesmer,
R.K.Sunahara,
R.A.Johnson,
G.Gosselin,
A.G.Gilman,
S.R.Sprang.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Adenylyl cyclase (AC) converts adenosine triphosphate (ATP) to cyclic adenosine
monophosphate, a ubiquitous second messenger that regulates many cellular
functions. Recent structural studies have revealed much about the structure and
function of mammalian AC but have not fully defined its active site or catalytic
mechanism. Four crystal structures were determined of the catalytic domains of
AC in complex with two different ATP analogs and various divalent metal ions.
These structures provide a model for the enzyme-substrate complex and
conclusively demonstrate that two metal ions bind in the active site. The
similarity of the active site of AC to those of DNA polymerases suggests that
the enzymes catalyze phosphoryl transfer by the same two-metal-ion mechanism and
likely have evolved from a common ancestor.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
Figure 1.
Fig. 1. Complexes of ATP analog inhibitors with the catalytic
core of AC (31). (A) The C[1a]:C[2a] catalytic core of AC viewed
along its pseudo-twofold axis toward what is believed to be the
cytoplasmic face of the molecule. Forskolin (FSK) and ATP, which
bind between the C[1a] (tan) and C[2a] (mauve) domains, are
shown as stick models. The switch II helix of G[s] , which
forms much of the interface with AC, is depicted as a red rod.
(B) Model of ATP bound in the active site. The side chain of
N1025 is modeled after its conformation in the AC · ATP
S-R[p]
· Mn structure (Fig. 1D), whereas all other elements are
those of the AC · LddATP
· Mn structure (Fig. 1C). Thin black lines depict the
coordination of the metal ions. The fifth ligand to metal A is a
carboxylate oxygen from D440 and is obscured in this view.
Protein and inhibitor residues are drawn as stick models, metals
as magenta metallic spheres, and water molecules as red spheres.
Carbon atoms are gray, nitrogens blue, oxygens red, phosphorous
green, and sulfur yellow. Amino acids are labeled according to
their position in canine type V AC for C[1a] and rat type II AC
for C[2a]. (C) The left panel portrays the active site of the
AC · LddATP
· Mn complex. Secondary structure is labeled as
previously defined (5). Superimposed is electron density from a
2.8 Å resolution |F[o[Mg]]| |F[c]|
omit map (blue wire cage) contoured at 2.5 .
Structural elements donated by the C[1a] and C[2a] domains of AC
are shown in tan and mauve, respectively. The right panel is a
closeup of the triphosphate of the inhibitor. For clarity, the
image has been rotated slightly from the view in the left panel.
The green and purple wire cages represent electron density
contoured at 5 for 3.0
Å |F[o[Zn]]|
|F[o[Mg]]| and 2.8 Å |F[o[Mn ]]|
|F[o[Mg]]| omit maps, respectively, demonstrating that Zn^2+
preferentially binds at site A and Mn^2+ at site B. The peak
height is 8.2 for the
Zn^2+ electron density and 11.3 for Mn^2+.
|F[o[Mg]]|, |F[o[Mn]]|, and |F[o[Zn]]| are the observed
structure factor amplitudes of the AC · LddATP
· Mg, AC · LddATP
· Mn, and AC · LddATP
· Zn data sets, respectively. (D) The active site of AC
· ATP S-R[p]
· Mn (left) and a closeup view of its thiotriphosphate
(right). Superimposed is electron density from a 3.0 Å
|F[o]| |F[c]|
omit map contoured at 2.5 . A 7 peak marks
the position of metal B and is modeled as Mn^2+. A 2 peak marks
the position of metal A and is modeled as Mg^2+, although it
could also be a weakly bound Mn^2+.
|
 |
|
|
|
| |
The above figure is
reprinted
by permission from the AAAs:
Science
(1999,
285,
756-760)
copyright 1999.
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
K.S.Misono,
J.S.Philo,
T.Arakawa,
C.M.Ogata,
Y.Qiu,
H.Ogawa,
and
H.S.Young
(2011).
Structure, signaling mechanism and regulation of the natriuretic peptide receptor guanylate cyclase.
|
| |
FEBS J, 278,
1818-1829.
|
 |
|
|
|
|
 |
L.Martínez,
T.E.Malliavin,
and
A.Blondel
(2011).
Mechanism of reactant and product dissociation from the anthrax edema factor: A locally enhanced sampling and steered molecular dynamics study.
|
| |
Proteins, 79,
1649-1661.
|
 |
|
|
|
|
 |
M.H.Gao,
and
H.K.Hammond
(2011).
Unanticipated signaling events associated with cardiac adenylyl cyclase gene transfer.
|
| |
J Mol Cell Cardiol, 50,
751-758.
|
 |
|
|
|
|
 |
S.J.Hyde,
B.E.Eckenroth,
B.A.Smith,
W.A.Eberley,
N.H.Heintz,
J.E.Jackman,
and
S.Doublié
(2010).
tRNA(His) guanylyltransferase (THG1), a unique 3'-5' nucleotidyl transferase, shares unexpected structural homology with canonical 5'-3' DNA polymerases.
|
| |
Proc Natl Acad Sci U S A, 107,
20305-20310.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Wachten,
N.Masada,
L.J.Ayling,
A.Ciruela,
V.O.Nikolaev,
M.J.Lohse,
and
D.M.Cooper
(2010).
Distinct pools of cAMP centre on different isoforms of adenylyl cyclase in pituitary-derived GH3B6 cells.
|
| |
J Cell Sci, 123,
95.
|
 |
|
|
|
|
 |
K.H.Biswas,
A.R.Shenoy,
A.Dutta,
and
S.S.Visweswariah
(2009).
The evolution of guanylyl cyclases as multidomain proteins: conserved features of kinase-cyclase domain fusions.
|
| |
J Mol Evol, 68,
587-602.
|
 |
|
|
|
|
 |
L.Martínez,
E.Laine,
T.E.Malliavin,
M.Nilges,
and
A.Blondel
(2009).
ATP conformations and ion binding modes in the active site of anthrax edema factor: a computational analysis.
|
| |
Proteins, 77,
971-983.
|
 |
|
|
|
|
 |
P.D.Townsend,
P.M.Holliday,
S.Fenyk,
K.C.Hess,
M.A.Gray,
D.R.Hodgson,
and
M.J.Cann
(2009).
Stimulation of Mammalian G-protein-responsive Adenylyl Cyclases by Carbon Dioxide.
|
| |
J Biol Chem, 284,
784-791.
|
 |
|
|
|
|
 |
R.Sadana,
and
C.W.Dessauer
(2009).
Physiological roles for G protein-regulated adenylyl cyclase isoforms: insights from knockout and overexpression studies.
|
| |
Neurosignals, 17,
5.
|
 |
|
|
|
|
 |
S.Pierre,
T.Eschenhagen,
G.Geisslinger,
and
K.Scholich
(2009).
Capturing adenylyl cyclases as potential drug targets.
|
| |
Nat Rev Drug Discov, 8,
321-335.
|
 |
|
|
|
|
 |
T.C.Mou,
N.Masada,
D.M.Cooper,
and
S.R.Sprang
(2009).
Structural basis for inhibition of mammalian adenylyl cyclase by calcium.
|
| |
Biochemistry, 48,
3387-3397.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
W.J.Tang,
and
Q.Guo
(2009).
The adenylyl cyclase activity of anthrax edema factor.
|
| |
Mol Aspects Med, 30,
423-430.
|
 |
|
|
|
|
 |
A.Rauch,
M.Leipelt,
M.Russwurm,
and
C.Steegborn
(2008).
Crystal structure of the guanylyl cyclase Cya2.
|
| |
Proc Natl Acad Sci U S A, 105,
15720-15725.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
C.Schlicker,
A.Rauch,
K.C.Hess,
B.Kachholz,
L.R.Levin,
J.Buck,
and
C.Steegborn
(2008).
Structure-based development of novel adenylyl cyclase inhibitors.
|
| |
J Med Chem, 51,
4456-4464.
|
 |
|
|
|
|
 |
D.Bandyopadhyay,
and
E.L.Mehler
(2008).
Quantitative expression of protein heterogeneity: Response of amino acid side chains to their local environment.
|
| |
Proteins, 72,
646-659.
|
 |
|
|
|
|
 |
D.Chen,
M.Misra,
L.Sower,
J.W.Peterson,
G.E.Kellogg,
and
C.H.Schein
(2008).
Novel inhibitors of anthrax edema factor.
|
| |
Bioorg Med Chem, 16,
7225-7233.
|
 |
|
|
|
|
 |
J.A.Winger,
E.R.Derbyshire,
M.H.Lamers,
M.A.Marletta,
and
J.Kuriyan
(2008).
The crystal structure of the catalytic domain of a eukaryotic guanylate cyclase.
|
| |
BMC Struct Biol, 8,
42.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.J.Tesmer
(2008).
Guanylyl cyclase sees the light.
|
| |
J Biol, 7,
31.
|
 |
|
|
|
|
 |
J.U.Linder,
and
J.E.Schultz
(2008).
Versatility of signal transduction encoded in dimeric adenylyl cyclases.
|
| |
Curr Opin Struct Biol, 18,
667-672.
|
 |
|
|
|
|
 |
C.R.Pigott,
and
D.J.Ellar
(2007).
Role of receptors in Bacillus thuringiensis crystal toxin activity.
|
| |
Microbiol Mol Biol Rev, 71,
255-281.
|
 |
|
|
|
|
 |
D.Chen,
G.Menche,
T.D.Power,
L.Sower,
J.W.Peterson,
and
C.H.Schein
(2007).
Accounting for ligand-bound metal ions in docking small molecules on adenylyl cyclase toxins.
|
| |
Proteins, 67,
593-605.
|
 |
|
|
|
|
 |
J.L.Wang,
J.X.Guo,
Q.Y.Zhang,
J.J.Wu,
R.Seifert,
and
G.H.Lushington
(2007).
A conformational transition in the adenylyl cyclase catalytic site yields different binding modes for ribosyl-modified and unmodified nucleotide inhibitors.
|
| |
Bioorg Med Chem, 15,
2993-3002.
|
 |
|
|
|
|
 |
P.M.Gordon,
R.Fong,
and
J.A.Piccirilli
(2007).
A second divalent metal ion in the group II intron reaction center.
|
| |
Chem Biol, 14,
607-612.
|
 |
|
|
|
|
 |
P.Wassmann,
C.Chan,
R.Paul,
A.Beck,
H.Heerklotz,
U.Jenal,
and
T.Schirmer
(2007).
Structure of BeF3- -modified response regulator PleD: implications for diguanylate cyclase activation, catalysis, and feedback inhibition.
|
| |
Structure, 15,
915-927.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Conti,
E.Reitano,
and
E.Cattaneo
(2006).
Neural stem cell systems: diversities and properties after transplantation in animal models of diseases.
|
| |
Brain Pathol, 16,
143-154.
|
 |
|
|
|
|
 |
X.Zhang,
M.Candas,
N.B.Griko,
R.Taussig,
and
L.A.Bulla
(2006).
A mechanism of cell death involving an adenylyl cyclase/PKA signaling pathway is induced by the Cry1Ab toxin of Bacillus thuringiensis.
|
| |
Proc Natl Acad Sci U S A, 103,
9897-9902.
|
 |
|
|
|
|
 |
C.Steegborn,
T.N.Litvin,
L.R.Levin,
J.Buck,
and
H.Wu
(2005).
Bicarbonate activation of adenylyl cyclase via promotion of catalytic active site closure and metal recruitment.
|
| |
Nat Struct Mol Biol, 12,
32-37.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.A.Doudna,
and
J.R.Lorsch
(2005).
Ribozyme catalysis: not different, just worse.
|
| |
Nat Struct Mol Biol, 12,
395-402.
|
 |
|
|
|
|
 |
J.J.Tesmer
(2005).
A seminal study of soluble adenylyl cyclase.
|
| |
Nat Struct Mol Biol, 12,
7-8.
|
 |
|
|
|
|
 |
L.I.Castro,
C.Hermsen,
J.E.Schultz,
and
J.U.Linder
(2005).
Adenylyl cyclase Rv0386 from Mycobacterium tuberculosis H37Rv uses a novel mode for substrate selection.
|
| |
FEBS J, 272,
3085-3092.
|
 |
|
|
|
|
 |
S.C.Sinha,
M.Wetterer,
S.R.Sprang,
J.E.Schultz,
and
J.U.Linder
(2005).
Origin of asymmetry in adenylyl cyclases: structures of Mycobacterium tuberculosis Rv1900c.
|
| |
EMBO J, 24,
663-673.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.Shen,
N.L.Zhukovskaya,
Q.Guo,
J.Florián,
and
W.J.Tang
(2005).
Calcium-independent calmodulin binding and two-metal-ion catalytic mechanism of anthrax edema factor.
|
| |
EMBO J, 24,
929-941.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.D.Ketkar,
A.R.Shenoy,
M.M.Kesavulu,
S.S.Visweswariah,
and
K.Suguna
(2004).
Purification, crystallization and preliminary X-ray diffraction analysis of the catalytic domain of adenylyl cyclase Rv1625c from Mycobacterium tuberculosis.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
371-373.
|
 |
|
|
|
|
 |
C.Chan,
R.Paul,
D.Samoray,
N.C.Amiot,
B.Giese,
U.Jenal,
and
T.Schirmer
(2004).
Structural basis of activity and allosteric control of diguanylate cyclase.
|
| |
Proc Natl Acad Sci U S A, 101,
17084-17089.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Russwurm,
and
D.Koesling
(2004).
NO activation of guanylyl cyclase.
|
| |
EMBO J, 23,
4443-4450.
|
 |
|
|
|
|
 |
P.Pellicena,
D.S.Karow,
E.M.Boon,
M.A.Marletta,
and
J.Kuriyan
(2004).
Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclases.
|
| |
Proc Natl Acad Sci U S A, 101,
12854-12859.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.S.Jaiswal,
and
M.Conti
(2003).
Calcium regulation of the soluble adenylyl cyclase expressed in mammalian spermatozoa.
|
| |
Proc Natl Acad Sci U S A, 100,
10676-10681.
|
 |
|
|
|
|
 |
C.Sztalryd,
G.Xu,
H.Dorward,
J.T.Tansey,
J.A.Contreras,
A.R.Kimmel,
and
C.Londos
(2003).
Perilipin A is essential for the translocation of hormone-sensitive lipase during lipolytic activation.
|
| |
J Cell Biol, 161,
1093-1103.
|
 |
|
|
|
|
 |
A.R.Shenoy,
N.Srinivasan,
and
S.S.Visweswariah
(2002).
The ascent of nucleotide cyclases: conservation and evolution of a theme.
|
| |
J Biosci, 27,
85-91.
|
 |
|
|
|
|
 |
C.Moorman,
and
R.H.Plasterk
(2002).
Functional characterization of the adenylyl cyclase gene sgs-1 by analysis of a mutational spectrum in Caenorhabditis elegans.
|
| |
Genetics, 161,
133-142.
|
 |
|
|
|
|
 |
I.Sokal,
A.Alekseev,
W.Baehr,
F.Haeseleer,
and
K.Palczewski
(2002).
Soluble fusion proteins between single transmembrane photoreceptor guanylyl cyclases and their activators.
|
| |
Biochemistry, 41,
251-257.
|
 |
|
|
|
|
 |
T.Kanacher,
A.Schultz,
J.U.Linder,
and
J.E.Schultz
(2002).
A GAF-domain-regulated adenylyl cyclase from Anabaena is a self-activating cAMP switch.
|
| |
EMBO J, 21,
3672-3680.
|
 |
|
|
|
|
 |
W.E.Meador,
and
F.A.Quiocho
(2002).
Man bites dog.
|
| |
Nat Struct Biol, 9,
156-158.
|
 |
|
|
|
|
 |
B.Bieger,
and
L.O.Essen
(2001).
Structural analysis of adenylate cyclases from Trypanosoma brucei in their monomeric state.
|
| |
EMBO J, 20,
433-445.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
B.Wedel,
and
D.Garbers
(2001).
The guanylyl cyclase family at Y2K.
|
| |
Annu Rev Physiol, 63,
215-233.
|
 |
|
|
|
|
 |
C.L.Drum,
Y.Shen,
P.A.Rice,
A.Bohm,
and
W.J.Tang
(2001).
Crystallization and preliminary X-ray study of the edema factor exotoxin adenylyl cyclase domain from Bacillus anthracis in the presence of its activator, calmodulin.
|
| |
Acta Crystallogr D Biol Crystallogr, 57,
1881-1884.
|
 |
|
|
|
|
 |
J.Pei,
and
N.V.Grishin
(2001).
GGDEF domain is homologous to adenylyl cyclase.
|
| |
Proteins, 42,
210-216.
|
 |
|
|
|
|
 |
J.Roelofs,
M.Meima,
P.Schaap,
and
P.J.Van Haastert
(2001).
The Dictyostelium homologue of mammalian soluble adenylyl cyclase encodes a guanylyl cyclase.
|
| |
EMBO J, 20,
4341-4348.
|
 |
|
|
|
|
 |
V.Tereshko,
S.T.Wallace,
N.Usman,
F.E.Wincott,
and
M.Egli
(2001).
X-ray crystallographic observation of "in-line" and "adjacent" conformations in a bulged self-cleaving RNA/DNA hybrid.
|
| |
RNA, 7,
405-420.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
Y.L.Guo,
T.Seebacher,
U.Kurz,
J.U.Linder,
and
J.E.Schultz
(2001).
Adenylyl cyclase Rv1625c of Mycobacterium tuberculosis: a progenitor of mammalian adenylyl cyclases.
|
| |
EMBO J, 20,
3667-3675.
|
 |
|
|
|
|
 |
F.Laliberté,
Y.Han,
A.Govindarajan,
A.Giroux,
S.Liu,
B.Bobechko,
P.Lario,
A.Bartlett,
E.Gorseth,
M.Gresser,
and
Z.Huang
(2000).
Conformational difference between PDE4 apoenzyme and holoenzyme.
|
| |
Biochemistry, 39,
6449-6458.
|
 |
|
|
|
|
 |
J.A.Ochoa De Alda,
G.Ajlani,
and
J.Houmard
(2000).
Synechocystis strain PCC 6803 cya2, a prokaryotic gene that encodes a guanylyl cyclase.
|
| |
J Bacteriol, 182,
3839-3842.
|
 |
|
|
|
|
 |
J.Blaszczyk,
G.Shi,
H.Yan,
and
X.Ji
(2000).
Catalytic center assembly of HPPK as revealed by the crystal structure of a ternary complex at 1.25 A resolution.
|
| |
Structure, 8,
1049-1058.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
J.J.Tesmer,
C.W.Dessauer,
R.K.Sunahara,
L.D.Murray,
R.A.Johnson,
A.G.Gilman,
and
S.R.Sprang
(2000).
Molecular basis for P-site inhibition of adenylyl cyclase.
|
| |
Biochemistry, 39,
14464-14471.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
K.Vijayachandra,
M.Guruprasad,
R.Bhandari,
U.H.Manjunath,
B.P.Somesh,
N.Srinivasan,
K.Suguna,
and
S.S.Visweswariah
(2000).
Biochemical characterization of the intracellular domain of the human guanylyl cyclase C receptor provides evidence for a catalytically active homotrimer.
|
| |
Biochemistry, 39,
16075-16083.
|
 |
|
|
|
|
 |
H.Ago,
T.Adachi,
A.Yoshida,
M.Yamamoto,
N.Habuka,
K.Yatsunami,
and
M.Miyano
(1999).
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.
|
| |
Structure, 7,
1417-1426.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
| |